Improvement of matched sibling donor engraftment with sirolimus added to a non-myeloablative conditioning regimen

被引：0
|
作者：
Claxton, DF [1 ]
Ehmann, C [1 ]
Shaffer, M [1 ]
Rybka, W [1 ]
机构：
[1] Penn State Coll Med, Hershey, PA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.071
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
71
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [21] Kinetics of chimerism donor cells in different non-myeloablative conditioning regimens and GvHD
    Savino, L
    Carella, M
    Beltrami, G
    Greco, MM
    Centra, M
    Carella, AM
    BONE MARROW TRANSPLANTATION, 2004, 33 : S188 - S188
  • [22] Unrelated cord blood transplantation with non-myeloablative conditioning regimen in paediatric acute leukaemia
    Ahn, HS
    Kang, HJ
    Park, ES
    Choi, HS
    Shin, HY
    BONE MARROW TRANSPLANTATION, 2005, 35 : S365 - S365
  • [23] Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
    Mackinnon, S
    Kottaridis, P
    Perry, A
    Chakrabarti, S
    Milligan, DW
    Pettengell, R
    Chopra, R
    Morgan, G
    Hale, G
    Waldmann, H
    Linch, DC
    Devereux, S
    Goldstone, AH
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 31 - 31
  • [24] Immunotherapy of leukemia in conjunction with non-myeloablative conditioning: Engraftment of blood stem cells and eradication of host leukemia with non-myeloablative conditioning based on fludarabine and anti-thymocyte globulin (ATG)
    Slavin, S
    Nagler, A
    Naparstek, E
    Ackerstein, A
    Kapelushnik, Y
    Varadi, G
    Kirschbaum, M
    BenYosef, R
    Samuel, S
    Or, R
    BLOOD, 1996, 88 (10) : 2443 - 2443
  • [25] Durable engraftment of purified allogeneic hematopoietic stem cells following non-myeloablative conditioning.
    Muchmore, MEA
    Burge, MJ
    Shizuru, JA
    BLOOD, 2005, 106 (11) : 622A - 622A
  • [26] Infections after allogeneic haematopoietic stem cell transplantation with a non-myeloablative conditioning regimen
    Frere, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2005, 35 : S164 - S164
  • [27] Failure of a minimally toxic non-myeloablative regimen to establish stable donor engraftment after transplantation for sickle cell anemia and β-thalassemia.
    Iannone, R
    Casella, JF
    Fuchs, EJ
    Chen, AR
    Woolfrey, A
    Amylon, M
    Sullivan, KM
    Storb, RF
    Walters, MC
    BLOOD, 2002, 100 (11) : 46A - 46A
  • [28] Engraftment after non-myeloablative transplants; still an issue
    Schouten, HC
    Jansen, M
    Bos, G
    Jansen, RLH
    Lalisang, RI
    Wagstaff, J
    BONE MARROW TRANSPLANTATION, 2001, 27 : S292 - S292
  • [29] A novel cyclophosphamide (CTX) based non-myeloablative conditioning regimen: Induction of tolerance and effects of delayed donor lymphocyte infusions (DLI).
    Mapara, MY
    Swenson, K
    Zhao, GL
    Pearson, D
    Pelot, MR
    Sykes, M
    BLOOD, 1999, 94 (10) : 635A - 635A
  • [30] Non-myeloablative alemtuzumab/low dose total body irradiation conditioning for children undergoing HLA-matched sibling donor haematopoietic cell transplantation for sickle cell disease
    Gregory, G.
    Dania, M.
    Michael, L.
    Tony, T.
    Alberto, N-A
    Aisha, B.
    Catherine, C-B
    Sunil, D.
    Victor, L.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S436 - S437
12345